Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies

Authors
Schaffel, R Nucci, M Portugal, R Castro, MB Ferreira, SB Almeida, L Spector, N Pulcheri, W
Citation
R. Schaffel et al., Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies, CLIN INF D, 31(3), 2000, pp. 821-822
Citations number
9
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
31
Issue
3
Year of publication
2000
Pages
821 - 822
Database
ISI
SICI code
1058-4838(200009)31:3<821:TFTTOS>2.0.ZU;2-D
Abstract
A total of 21 patients with hematologic malignancies were given thiabendazo le for treatment of strongyloidiasis. Fifteen patients were cured. Since th ere were no relapses, it is unlikely that maintenance therapy has a role in the management of strongyloidiasis in this population of patients.